Renal outcomes of rivaroxaban compared with warfarin in Asian patients with nonvalvular atrial fibrillation: A nationwide population-based cohort study

BACKGROUND: Further studies are needed to expand the evidence for the association of rivaroxaban with a lower risk of adverse renal outcomes in patients with atrial fibrillation (AF) as compared with warfarin, especially in Asians. OBJECTIVES: To determine whether there are differences in adverse re...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, So-Ryoung, Choi, Eue-Keun, Park, Sang-Hyun, Han, Kyung-Do, Oh, Seil, Abdelgawwad, Khaled, Lip, Gregory Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996329/
https://www.ncbi.nlm.nih.gov/pubmed/36910528
http://dx.doi.org/10.3389/fcvm.2023.1040834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996329/
https://www.ncbi.nlm.nih.gov/pubmed/36910528
http://dx.doi.org/10.3389/fcvm.2023.1040834

Ejemplares similares